PF582 (ranibizumab biosimilar) - Pfenex
Lucentis (ranibizumab) - Roche, Novartis
PFEnex: Corporate Presentation (Pfenex) - Sep 18, 2016 - "Initial comparative clinical study results: PF582 v. Lucentis" 
P1/2 data • Biosimilar
http://www.pfenex.com/
 
Sep 18, 2016
 
 
5b81dc25-b44f-44b1-a949-5d029db51c3a.jpg

e17157da-b6b0-45fb-9604-ed668f0b47c9.jpg